T 2 -weighted MR images, the mass was hyperintense and surrounded by edema (Fig. 1C) . The patient was therefore transferred to our department.
Examination and Further Assessment. At admission, the patient had a temperature of 38.5˚C, a stiff neck, sore muscles and joints, and normal fundus oculi and internal organs, including liver and spleen. No peripheral lymph nodes were noted. Laboratory findings included a 36.8% hematocrit level, a hemoglobin count of 10.9 g/dl, mean corpuscular volume of 84 fl, mean corpuscular hemoglobin of 25 pg, and mean corpuscular hemoglobin concentration of 29.4 g/dl. The white blood cell count showed a neutrophilic leukocytosis (10.89 ϫ 10 9 /L), and the ESR was elevated (70 mm/hour). An infectious disease was excluded by serological and CSF studies, the results of which were negative.
Operation. The patient underwent a right frontotemporal craniotomy, and an extrinsic, white, hard mass was removed. The meningioma attachment to the dura mater of the base of the middle fossa was also severed, the local bone being normal (Simpson Grade I excision).
Postoperative Course. In the immediate postoperative period, there was complete resolution of the fever with marked reduction of the headache, and pain in the muscles and joints was ameliorated. Three months after surgery, the hematological findings had returned to normal. Control MR studies confirmed the total excision of the tumor. Histopathological Findings. The tumor was fixed in formalin and embedded in paraffin according to standard procedures. Histological studies were performed with hematoxylin/eosin and reticulin silver staining. Slides were processed for immunohistochemistry on an automated staining system (Autostainer; Dako Cytomation, Glostrup, Denmark) by using antibodies for CD3 (dilution 1:100; Ylem, Avezzano, Italy), CD20 (dilution 1:200; Ylem), CD68 (PGM-1, dilution 1:400; Dako Cytomation), S100 (dilution 1:200; Ylem), CD34 (dilution 1:50; Dako Cytomation), SMA (dilution 1:100; Ylem), cytokeratins (ae1/ae3, dilution 1:100; Ylem), EMA (dilution 1:100; Ylem), GFAP (dilution 1:1000; Ylem), and vimentin (dilution 1:200; Ylem). The proliferation index was evaluated using the antibody against MIB-1 antigen (dilution 1:100; Dako Cytomation).
On microscopic examination, the tumor displayed two different components. The first component was that of elongated spindle cells with irregular nuclei, arranged in whorls and nests. The second component (80% of the tumor) consisted of chordoidlike features formed by epithelial-like cells, which were arranged in chords and dispersed in a myxoid background ( Fig. 2A ). Both components were positive for vimentin and EMA. The CD34, S100, SMA, GFAP, and cytokeratins were negative. The tumor showed a proliferation index (MIB-1 staining) of 8 to 10%. The mitotic range varied from 5 to 7 per 20 hpfs. A moderate inflammatory component was present throughout the tumor and was composed mainly of macrophages (CD68 positive) and T lymphocytes (CD3 positive). Only a few B lymphocytes (CD20 positive) were identifiable in the tumor.
The tumor specimens were also tested for the expression of IL-6 (dilution 1:20; R&D, Minneapolis, MN) and TNF␣ (dilution 1:50; Santa Cruz Biotechnology, Inc., Santa Cruz, CA). The tumor was focally positive for IL-6 ( Fig. 2B ) but not for TNF␣; isolated inflammatory cells, including macrophages and lymphocytes, were stained with anti-IL-6 antibody.
Discussion
Here we present an unusual case of an adult woman who developed a systemic inflammatory syndrome, mainly characterized by a febrile status and diffuse muscle and joint pain. After negative results of numerous examinations, an MR image of the brain revealed a right temporal mass for which the patient was transferred to our neurosurgical department. Immediately after excision of the tumor, which was a chordoid meningioma, the patient's febrile state resolved. To our knowledge, this case involves the second adult patient with a chordoid meningioma associated with a systemic inflammatory syndrome. Connors 2 reported the first case referable to a chordoid meningioma, which was later reviewed by Dimand and colleagues 5 Kepes and associates 9 introduced the term "chordoid meningioma" because of the chordoma-like histological appearance of the tumor, also characterized by a reactive infiltration of lymphocytes. In their series, patients were 8 to 19 years of age and presented with a systemic inflammatory syndrome, expressed by iron-refractory hypochromic/microcytic anemia, hepatosplenomegaly, bone marrow plasmacytosis, and dysgammaglobulinemia (Castleman syndrome), which disappeared after tumor removal. Such a variant of meningioma was included in the 1993 World Health Organization classification of tumors. 3 Sixty-seven cases of chordoid meningioma have been reported in the literature (Table 1 ). In 11 patients (mean age 18 years), a systemic inflammatory syndrome was also reported. 1, 9, 11, 13, 21 Nine of these patients had microcytic hypochromic anemia, three had severe headache, two had elevated ESRs, one had fever, and one had dysgammaglobulinemia. Symptoms and signs of a space-occupying intracranial mass as well as systemic manifestations improved after tumor removal. Very interestingly, in one patient, the disappearance of the anemia after tumor excision and its reappearance with marked arthralgia 3 years later after tumor recurrence, seem to demonstrate the correlation between meningioma and systemic manifestations. Fifty-three patients (mean age 47 years) with chordoid meningioma 3, 4, 7, 8, 14, 17, 19, [22] [23] [24] had symptoms related only to the space-occupying intracranial mass but not to any systemic inflammatory syndrome. In three cases, 6 ,12,18 information on systemic manifestations was not provided.
The role of lymphocyte infiltration in chordoid meningiomas is still unclear. Kobata, et al., 11 reported that the infiltration was mainly constituted by B lymphocytes and plasma cells in chordoid meningiomas whereas it was from T cells in all meningiomas. Moreover, it has been observed that the lymphocyte infiltration of chordoid meningiomas consisted mainly of B cells in young patients with systemic inflammatory syndrome and T cells in adult cases. 1, 3 It has been hypothesized that B-cell infiltration of the tumor could be characteristic in young patients with a systemic inflammatory syndrome. 1, 3 In our adult patient with a systemic inflammatory syndrome, however, the lymphocyte infiltration of the tumor consisted mainly of macrophages and T cells with a few B cells.
The cause of the systemic inflammatory syndrome in patients with chordoid meningioma is also still unclear. As the main pathophysiological mechanism, an immunological reaction associated with the characteristic lymphocytic infiltration has been suggested. 9 Civit and colleagues 1 proposed a chemical antigenic stimulus due to tumor cells.
Regarding a 9-year-old child affected by a rhabdoid atypical meningioma, Rittierodt and associates 16 suggested that the fever, headache, arthralgia, and hepatosplenomegaly could be caused by the pyrogenic cytokines TNF␣ and IL-6 produced by tumor cells. Similarly, in our case, the pyrogenic IL-6 was detected in the chordoid meningioma samples. It seems that IL-6 acts at the end of the cytokine cascade, leading to fever, 15 with the target being the anterior hypothalamus by signaling thermoregulatory neurons via prostaglandin-dependent pathways. 20 The removal of the mass, that is the elimination of the source of IL-6, could explain the immediate subsiding of the fever in our patient. Considering that fever may be caused by many types of pyrogens produced by inflammatory cells, such as inflammatory cytokines, prostaglandins, and free radicals, 20 and that the tumor in our patient was also infiltrated by inflammatory cells, we cannot attribute the fever only to IL-6 production.
Conclusions
Chordoid meningioma is mainly a tumor found in adults,
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Pyrogenic cytokine IL-6 expression by a chordoid meningioma and it is generally not associated with a systemic inflammatory syndrome. Conversely, in young patients, chordoid meningioma is frequently associated with a systemic inflammatory syndrome, mainly expressed by hypochromic/ microcytic anemia and/or fever, which usually disappear rapidly after tumor removal. In our case, although affecting an adult, the chordoid meningioma was associated with a systemic inflammatory syndrome. This syndrome was chiefly characterized by fever that completely disappeared after tumor excision. This pattern could be related to the production of IL-6 by tumor cells.
